Title : The significance of vasopressin as a pressor agent.

Pub. Date : 1984

PMID : 6206352






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In conscious rats with established deoxycorticosterone acetate (DOCA)/salt hypertension, d(CH2)5 Tyr (Me) AVP decreased systolic BP after acute administration. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus
2 In conscious rats with established deoxycorticosterone acetate (DOCA)/salt hypertension, d(CH2)5 Tyr (Me) AVP decreased systolic BP after acute administration. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus
3 When another, AVP-antagonist, d(CH2)5-D-Tyr (Et) VAVP, which blocks vascular and renal tubular AVP-receptors, was administered chronically, the development of DOCA/salt hypertension was prevented at the expense of severe and persistent hypernatremia. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus
4 When another, AVP-antagonist, d(CH2)5-D-Tyr (Et) VAVP, which blocks vascular and renal tubular AVP-receptors, was administered chronically, the development of DOCA/salt hypertension was prevented at the expense of severe and persistent hypernatremia. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus
5 These results demonstrate that under certain conditions the vascular effects of AVP may contribute to the maintenance of BP, AVP appears to participate in the pathogenesis of DOCA/salt hypertension through both its vasoconstrictor and its antidiuretic effects. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus